This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Assia Chemical Industries Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Abed Masarwa: Innovator in Pharmaceutical Chemistry
Introduction
Abed Masarwa, a talented inventor based in Tayibe, Israel, has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio that includes a patent in solid-state forms of valbenazine, his work focuses on advancing therapeutic options for various medical conditions.
Latest Patents
Abed Masarwa holds a patent for "Solid state forms of Valbenazine." This innovation encompasses the solid-state forms of valbenazine, along with its salts and the processes for preparation thereof. The patent further details the pharmaceutical compositions involving valbenazine and the intermediates used in its preparation, showcasing Masarwa's expertise in developing impactful pharmaceutical solutions.
Career Highlights
Abed is currently employed at Assia Chemical Industries Ltd., where he applies his innovative mindset to address challenges in pharmaceutical development. His dedication to advancing healthcare through chemical innovations has positioned him as a key player in his field.
Collaborations
Throughout his career, Abed has collaborated with notable colleagues such as Ariel Mittelman and Sharona Shachan-Tov. These partnerships have enhanced his research efforts, contributing to the successful development of pharmaceutical products and formulations.
Conclusion
Abed Masarwa is a remarkable inventor whose work in solid-state forms of valbenazine reflects his commitment to innovation in the pharmaceutical industry. His contributions are essential in paving the way for new therapeutic avenues, demonstrating the pivotal role that inventors play in enhancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile